Twist Bioscience (TWST) Other Operating Expenses (2017 - 2026)

Twist Bioscience (TWST) has reported Other Operating Expenses for 10 consecutive years, with $53.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 14.6% year-over-year to $53.6 million; the TTM figure through Mar 2026 stood at $152.2 million (up 64.26% YoY), while the FY2025 annual figure was $48.8 million, changed N/A from the prior year.
• Other Operating Expenses advanced to $53.6 million in Q1 2026 per TWST's latest filing, from $49.7 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $53.6 million in Q1 2026 and bottomed at -$5.9 million in Q3 2023.
• Historically, Other Operating Expenses has averaged $21.4 million across 5 years, with a median of $5.1 million in 2022.
• Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 324.22% — and 2023, when it plunged 603.66%.
• Twist Bioscience's Other Operating Expenses stood at $4.1 million in 2022, then tumbled by 243.0% to -$5.9 million in 2023, then soared by 875.8% to $45.9 million in 2024, then gained by 8.4% to $49.7 million in 2025, then rose by 7.78% to $53.6 million in 2026.
• Business Quant data shows TWST's Other Operating Expenses at $53.6 million in Q1 2026, $49.7 million in Q4 2025, and $48.8 million in Q2 2025.